Additionally, their high predictive accuracy confirms the usefulness of sdLDL and resistin as biomarkers for early risk assessment and shows how they can guide early intervention strategies for metabolic and cardiovascular risk linked to obesity. The gene discussed is RETN; the disease is Obesity.